Hayrı Topcu

Topçuoğlu Orman Ürünleri Yönetim Kurulu Baskani

[Eledon Pharmaceuticals, Inc. @Eledon_Pharma]

At $ELDN, we are advancing a new #immunosuppression approach with the potential to help prevent islet cell #transplant rejection. Curious about the science behind islet cell therapies? @BreakthroughT1D explains more in this article for the T1D community: https://t.co/UB89nSiXdo

[Novo Nordisk @novonordisk]

#PRESS We are announcing a new phase of our partnership with Aspect Biosystems to develop curative medicines for diabetes.

Learn more in our press release here: https://t.co/8yw270bPcK

[Hayrı Topcu @HayrTopcu]

Pankreasımız bozuk olsa bile hayatta yaşamaya değer çok şey var💙
Bir damla insülinin kıymetini bilen ve onunla can bulan tüm tip 1 diyabetlilerin diyabette farkındalık ayı kutlu olsun

[Hayrı Topcu @HayrTopcu]

https://t.co/4dqC1eCAX5

[Hayrı Topcu @HayrTopcu]

https://t.co/wpOe7VNOXp

[Semih Tareen @virusfantom]

Rusya kanser aşısı hakkında doğru bilgileri vereyim:
👉”Kullanıma hazır” değil henüz çünkü faz 1 çalışmaları yeni başladı/başlıyor. Henüz insan verisi yok. Kaynak: https://t.co/PAtvbJ52tb

[Hayrı Topcu @HayrTopcu]

https://t.co/q01tWtOjEV

[Hayrı Topcu @HayrTopcu]

https://t.co/iV2P15Ve2B

[Hayrı Topcu @HayrTopcu]

@pirferhat @RTErdogan @burhanduran Hayırlı olsun Tebrikler başarilar diliyorum

[Hayrı Topcu @HayrTopcu]

Sistemik sklerozlu bir hastada iPSC'den türetilmiş bir CD19/BCMA CAR-NK tedavisi: Hücre https://t.co/tGweFSCzqR

[Hayrı Topcu @HayrTopcu]

Otoimmün hastalık tedavisinde yeni gelişme:

Çin’de ilk kez (kutanöz sistemik sklerozlu) bir hastaya kök hücreden üretilmiş akıllı bağışıklık hücreleri (CAR-NK) verildi.

Bağışıklık sistemi resetlendi ve otoantikor üreten bağışıklık hücreleri seçici biçimde silindi

[Hayrı Topcu @HayrTopcu]

https://t.co/9RgqQAt3yG

[TVASurg @TVASurg]

📽️New video alert: Total pancreatectomy with islet cell auto-transplant for #pancreatitis

https://t.co/jzv5FZK42r

Special thanks to Dr. Trevor Reichman and Justin Manuel @UHNTransplant for this collaborative project on #tpiat!

[Breakthrough T1D @BreakthroughT1D]

Want to hear about all of the incredible type 1 diabetes (T1D) research updates coming out of the ADA Scientific Sessions?

Join us on Monday June 30 at 6pm ET to hear a full recap from Breakthrough T1D CEO, Dr. Aaron Kowalski! Tune in on any of our social media channels—you won’t want to miss it!

[Dr. Halis Kaan Akturk @Drhkakturk]

First study from @VertexPharma published @NEJM for stem cell for type 1 diabetes

[Prof. Dr. Güner Sönmez @DrGunerSonmez]

Geliştirdiği teknikler nedeniyle Amerikan Beyin Cerrahları Birliği tarafından “Yüzyılın Beyin Cerrahı” seçilen Gazi Yaşargil, vefat etti.

Binlerce insana şifa verdi, nice hayata umut oldu. Sadece ülkemiz için değil, tüm insanlık için eşsiz bir değerdi.

Allah rahmet eylesin.

[Hayrı Topcu @HayrTopcu]

@Msttopcuoglu Allah rahmet eylesin mekanı cennet olsun.

[Helmholtz Munich | @HelmholtzMunich @HelmholtzMunich]

New Study Reveals Key to How Pancreatic Insulin-Producing Beta Cells Are Formed🔬

👉https://t.co/bnhF0guidV

A team led by Prof. Henrik Semb, #HelmholtzMunich, has uncovered how immature pancreatic cells decide whether to become insulin-producing beta cells or glucagon-producing alpha cells – a discovery that could transform #diabetes treatment and regenerative medicine.

🔑 The Key? Cell Polarity!
Their research shows that changes in apical-basal polarity influence whether cells become beta or alpha cells, which control our blood sugar levels. This insight could pave the way for advanced stem cell therapies for diabetes.

💡 Why It Matters:
By manipulating these cellular signals, scientists could potentially create new beta cells, opening doors to curative diabetes treatments.

@helmholtz_diabc
#StemCells #DiabetesResearch #StemCellTherapy #Pancreas #RegenerativeMedicine #CellPolarity

[Dr.V.Mohan @drmohanv]

🚨 Breakthrough in Diabetes Research! 🧬

We are proud to announce a landmark discovery by Dr. V. Mohan, Dr. Radha Venkatesan & colleagues at Madras Diabetes Research Foundation (MDRF), Chennai in collaboration with Dr. Colin G Nichols & colleagues at Washington University School of Medicine, USA – a new subtype of MODY (Maturity-Onset Diabetes of the Young)! 🔬🌍

This rare genetic form of diabetes, typically seen in the young, could revolutionize the way MODY is diagnosed and treated globally.

📖 Read the article published in the prestigious journal ‘Diabetes’ by the American Diabetes Association:
👉 https://t.co/YrZGrq8Z1h

#MDRF #DiabetesResearch #MODY #GlobalBreakthrough #GeneticDiabetes #PrecisionMedicine #ProudMoment #Diabetes #Type1Diabetes #Type2Diabetes #DiabetesResearchIndia #NeonatalDiabetes #MonogenicDiabetes #Discovery #ICMR #IndianScience #IndianScientists #DiabetesDiscovery #DiabetesBreakthrough

@ICMRDELHI @ncdirindia @WHO @MoHFW_INDIA @Rssdi_official @ADA_DiabetesPro @DMDSC @WashU @washumedicine @PMOIndia @JPNadda @DrJitendraSingh @timesofindia @the_hindu @IntDiabetesFed @IndianExpress

[U.S. FDA @FDA]

In a historic first for the agency, @DrMakaryFDA today announced an aggressive timeline to scale use of artificial intelligence (AI) internally across all FDA centers by June 30, 2025, following the completion of a new generative AI pilot for scientific reviewers. https://t.co/93CBDxeS1v